ABIOMED Gets O.K. from FDA to Begin Human Implants of Artificial Heart
ABIOMED, Inc. (NASDAQ:ABMD), a leader in heart assist and replacement technology, announced today that it has received permission from the Food and […]
World's Largest Resource for Cardiovascular Perfusion
ABIOMED, Inc. (NASDAQ:ABMD), a leader in heart assist and replacement technology, announced today that it has received permission from the Food and […]
Stentless valves do not produce hemodynamically superior results over those provided by the more traditional stented valves, according to results from a […]
EuroSCORE II and the STS score are better calibrated than the logistic EuroSCORE but have moderate discrimination for predicting 30-day mortality after TAVR.